CurrentEndo
Get Weekly

CurrentEndo coverage · page 9 of 18

Osteoporosis International

Briefs 321–360 of 695 CurrentEndo has covered from this journal, newest publication first

Latest from Osteoporosis International

All coverage, newest first

  1. Osteoporos Int

    Elevated baseline CTX levels predict enhanced therapeutic efficacy of zoledronic acid in augmenting lumbar spine bone mineral density among Chinese osteoporosis patients

    Cohort studyBone & mineral

  2. Osteoporos Int

    Advancing trabecular bone score (TBS): clinical performance of TBS version 4.0 with direct correction for soft tissue thickness—the osteolaus study

    Cohort studyBone & mineral

  3. Osteoporos Int

    TBS as a complementary tool for assessing vertebral fractures and spinal deformity in children and adolescents with osteogenesis imperfecta

    Cross-sectional studyBone & mineral

  4. Osteoporos Int

    Long-term adherence to anti-osteoporosis medication and determinants of adherence in the population-based screening trial ROSE

    Secondary analysisBone & mineral

  5. Osteoporos Int

    The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population

    Cohort studyBone & mineral

  6. Osteoporos Int

    Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX

    Meta-analysisBone & mineral

  7. Osteoporos Int

    Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR)

    Cohort studyBone & mineral

  8. Osteoporos Int

    Evidence-based joint statement position of perioperative bone optimization in the arthroplasty candidate, from FEMECOT, AMMOM, ACOMM, SCCOT, SECOT, SEFRAOS, SEIOMM

    Guideline or statementBone & mineral

  9. Osteoporos Int

    The definition of atypical femoral fractures should include periprosthetic femoral fractures (PAFFs)

    Cohort studyBone & mineral

  10. Osteoporos Int

    Changing trends in bisphosphonate therapy: a twenty-five-year surveillance in a single US integrated healthcare system

    Cohort studyBone & mineral

  11. Osteoporos Int

    Identifying proximal humerus fractures: an algorithmic approach using registers and radiological visit data

    Diagnostic or prognostic studyBone & mineral

  12. Osteoporos Int

    Identifying rare variants in genes related to bone phenotypes in a cohort of postmenopausal women

    Cohort studyBone & mineral

  13. Osteoporos Int

    Effects of combined protein and exercise interventions on bone health in middle-aged and older adults — A systematic literature review and meta-analysis of randomized controlled trials

    Meta-analysisBone & mineral

  14. Osteoporos Int

    Association between vertebral fractures and brain volume: insights from a community cohort study

    Cross-sectional studyBone & mineral

  15. Osteoporos Int

    Ultra-processed food intake and prevalence of osteoporosis in US adults aged 50 years and older: a cross-sectional analysis

    Cross-sectional studyBone & mineral

  16. Osteoporos Int

    Metaphyseal comminution in distal radius fractures: a predictor of secondary fragility fractures and the role of osteoporosis treatment

    Cohort studyBone & mineral

  17. Osteoporos Int

    Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA, 2005–2018

    Cross-sectional studyBone & mineral

  18. Osteoporos Int

    Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case–control study

    Case-control studyBone & mineral

  19. Osteoporos Int

    A novel hybrid deep learning framework based on biplanar X-ray radiography images for bone density prediction and classification

    Diagnostic or prognostic studyBone & mineral

  20. Osteoporos Int

    Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020

    Cohort studyBone & mineral

  21. Osteoporos Int

    Effect of romosozumab on bone mineral density and trabecular bone score in premenopausal women with low bone mass

    Cohort studyBone & mineral

  22. Osteoporos Int

    Fracture liaison service (FLS) is associated with lower subsequent fragility fracture risk and mortality: NoFRACT (the Norwegian capture the fracture initiative)

    Randomized controlled trialBone & mineral

  23. Osteoporos Int

    Clinical experience with denosumab discontinuation

    Cohort studyBone & mineral

  24. Osteoporos Int

    Is there an association between birth characteristics and fractures in young adults? The HUNT Study, Norway

    Cohort studyBone & mineral

  25. Osteoporos Int

    Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study

    Cohort studyBone & mineral

  26. Osteoporos Int

    The association between blood cadmium levels and bone mineral density in U.S. adolescents aged 12–19 years

    Cross-sectional studyBone & mineral

  27. Osteoporos Int

    Cervicothoracic volumetric bone mineral density assessed by opportunistic QCT may be a reliable marker for osteoporosis in adults

    Diagnostic or prognostic studyBone & mineral

  28. Osteoporos Int

    Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis

    Research articleBone & mineral

  29. Osteoporos Int

    Osteoporotic fracture risks of thiazides and dihydropyridines in angiotensin modulator users

    Cohort studyBone & mineral

  30. Osteoporos Int

    The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates—a single-center retrospective study

    Cohort studyBone & mineral

  31. Osteoporos Int

    The effect of denosumab on minimum 3-years BMD changes in patients with osteoporotic hip fractures: a propensity score matching analysis

    Cohort studyBone & mineral

  32. Osteoporos Int

    Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization for fragility fractures

    Cohort studyBone & mineral

  33. Osteoporos Int

    Gut microbiome and bone health: update on mechanisms, clinical correlations, and possible treatment strategies

    Meta-analysisBone & mineral

  34. Osteoporos Int

    Bisphosphonate drug holidays in osteoporosis according to fracture risk profile

    Cohort studyBone & mineral

  35. Osteoporos Int

    Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005–2018

    Cross-sectional studyBone & mineral

  36. Osteoporos Int

    Effect of yoga on balance, falls, and bone metabolism: a systematic review of randomized controlled trials in healthy individuals

    Meta-analysisBone & mineral

  37. Osteoporos Int

    Association of standardized serum 25-hydroxyvitamin D with falls in post-menopausal women

    Secondary analysisReproductive endocrine

  38. Osteoporos Int

    Choose your mother wisely: the familial resemblance of bone adaptation

    Cross-sectional studyBone & mineral

  39. Osteoporos Int

    Real-world rates and risk factors for subsequent treatment with vertebroplasty or balloon kyphoplasty after initial vertebral augmentation: a retrospective cohort study

    Cohort studyBone & mineral

  40. Osteoporos Int

    Osteoporosis testing and treatment remain low in both Traditional Medicare and Medicare Advantage

    Cross-sectional studyBone & mineral

All 695 Briefs in ExploreShowing Briefs 321–360 of 695, newest first